Cargando…
Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer
BACKGROUND: The association between benign prostatic hyperplasia (BPH) and prostate cancer (PCa) remains controversial, largely due to a detection bias in traditional observational studies. OBJECTIVE: To assess the association between BPH and PCa using inherited single nucleotide polymorphisms (SNPs...
Autores principales: | Glaser, Alexander, Shi, Zhuqing, Wei, Jun, Lanman, Nadia A., Ladson-Gary, Skylar, Vickman, Renee E., Franco, Omar E., Crawford, Susan E., Lilly Zheng, S., Hayward, Simon W., Isaacs, William B., Helfand, Brian T., Xu, Jianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638770/ https://www.ncbi.nlm.nih.gov/pubmed/36353071 http://dx.doi.org/10.1016/j.euros.2022.07.004 |
Ejemplares similares
-
Oral desmopressin in nocturia with benign prostatic hyperplasia: A systematic review of the literature
por: Taha, Diaa-Eldin, et al.
Publicado: (2018) -
The role of Rezum in the management of refractory urinary retention due to benign prostate hyperplasia: A literature review
por: Khalil, Ibrahim A., et al.
Publicado: (2023) -
Simultaneous antegrade and retrograde endoscopic surgery for benign prostatic hyperplasia with vesical calculi – A single-centre experience
por: Javali, Tarun, et al.
Publicado: (2018) -
WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30–80-cm(3) and 80–150-cm(3) Prostates
por: Nguyen, David-Dan, et al.
Publicado: (2021) -
Transperineal intraprostatic injection of botulinum neurotoxin A vs transurethral resection of prostate for management of lower urinary tract symptoms secondary to benign prostate hyperplasia: A prospective randomised study
por: El-Dakhakhny, Amr S., et al.
Publicado: (2019)